Tuesday, April 25, 2017 1:32:16 AM
In the clinical trials in Nigeria, they were looking for an increase in CD4 count in at least 25% of the patients taking LDN, and the results showed that 44% of the patients had in increase in CD4 count after taking LDN (I'm pretty sure that's correct, but not 100% sure - or maybe it was that they were looking for a 25% increase in CD4 count and found 44%, I forget exactly). In addition to that, LDN is more effective in treating other diseases besides HIV / AIDS. I believe it is most effect in treating Crohn's disease, with something like a 75% success rate. I believe Cytocom (55% owned by IMUN) has already passed a Phase II trial in the United States with LDN for Crohn's disease. There is info on Cytocom's website about it.
To get an answer to your question, you should contact the company directly, or you might be able to find what you're looking for on www.lowdosenaltrexone.org, but I don't know anything about these trials in England that you're referring to.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM